The Supreme Court has deferred hearing for two weeks on a petition seeking a CBI Investigation to COVID-19 patients to use two antiviral drugs as treatment. Chief Justice SA Bobde has told the petitioner that the drug is approved by the government.
Also Read: Bigger blow to Center from Supreme Court, Arbitration award of billions of rupees in favor of Vedanta
The court said that the petitioner should first study it and then come to court. Petitioner Manohar Lal Sharma had said that the drug is already being sold without any clinical trials. Petitioner advocate Manohar Lal Sharma
Has also filed an FIR and sought legal action by the CBI against Indian pharmaceutical companies for the manufacture and sale of Remedacivir and Favipiravir as drugs that treat COVID-19 patients without a valid license.
Also read: Investigation agencies do not take any action in cases related to MP-MLA: Supreme Court
ML Sharma has demanded legal action against 10 pharma companies and has been accused of using 'media publicity' as a vaccine for Kovid and exploiting citizens living in fear of corona.
Ravish Kumar's Prime Time: Is Electronic Media Working Fair?